Kuojun Zhang

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 12

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Tyrosine Kinase

Photodynamic Therapy

Top Venues

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Wenhua Jiang, Qiangqiang Hou, Hongrui Xu, Kexin Yang, Xiaohui Wang, Kuojun Zhang, Yi Zeng, Wenqiang Li, Bingrui Wang, Guangmei Luo, Xiaofan Zhao, Hui Shen, Yong Xu, Xiaoxing Wu
Discovery of Novel Phenoxyaryl Pyridones as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with High Selectivity for the Second Bromodomain (BD2) to Potentially Treat Acute Myeloid Leukemia. Journal of medicinal chemistry 67 (2) (2024)
Lixin Zhou, Jiamei Yang, Kuojun Zhang, Tianyu Wang, Sheng Jiang, Xiangyu Zhang
Rising Star in Immunotherapy: Development and Therapeutic Potential of Small-Molecule Inhibitors Targeting Casitas B Cell Lymphoma-b (Cbl-b). Journal of medicinal chemistry 67 (2) (2024)
Lixin Zhou, Jiamei Yang, Kuojun Zhang, Tianyu Wang, Sheng Jiang, Xiangyu Zhang
Rising Star in Immunotherapy: Development and Therapeutic Potential of Small-Molecule Inhibitors Targeting Casitas B Cell Lymphoma-b (Cbl-b). Journal of medicinal chemistry 67 (2) (2024)
Lixin Zhou, Jiamei Yang, Kuojun Zhang, Tianyu Wang, Sheng Jiang, Xiangyu Zhang
Rising Star in Immunotherapy: Development and Therapeutic Potential of Small-Molecule Inhibitors Targeting Casitas B Cell Lymphoma-b (Cbl-b). Journal of medicinal chemistry 67 (2) (2024)
Lixin Zhou, Jiamei Yang, Kuojun Zhang, Tianyu Wang, Sheng Jiang, Xiangyu Zhang
Rising Star in Immunotherapy: Development and Therapeutic Potential of Small-Molecule Inhibitors Targeting Casitas B Cell Lymphoma-b (Cbl-b). Journal of medicinal chemistry (2024)
Wenhua Jiang, Qiangqiang Hou, Hongrui Xu, Kexin Yang, Xiaohui Wang, Kuojun Zhang, Yi Zeng, Wenqiang Li, Bingrui Wang, Guangmei Luo, Xiaofan Zhao, Hui Shen, Yong Xu, Xiaoxing Wu
Discovery of Novel Phenoxyaryl Pyridones as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with High Selectivity for the Second Bromodomain (BD2) to Potentially Treat Acute Myeloid Leukemia. Journal of medicinal chemistry (2024)
Wenhua Jiang, Qiangqiang Hou, Hongrui Xu, Kexin Yang, Xiaohui Wang, Kuojun Zhang, Yi Zeng, Wenqiang Li, Bingrui Wang, Guangmei Luo, Xiaofan Zhao, Hui Shen, Yong Xu, Xiaoxing Wu
Discovery of Novel Phenoxyaryl Pyridones as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with High Selectivity for the Second Bromodomain (BD2) to Potentially Treat Acute Myeloid Leukemia. Journal of medicinal chemistry 67 (2) (2024)
Kaizhen Wang, Xiangyu Zhang, Yao Cheng, Zhihao Qi, Ke Ye, Kuojun Zhang, Sheng Jiang, Yi Liu, Yibei Xiao, Tianyu Wang
Discovery of Novel PD-L1 Inhibitors That Induce the Dimerization, Internalization, and Degradation of PD-L1 Based on the Fragment Coupling Strategy. Journal of medicinal chemistry 66 (24) (2023)
Kaizhen Wang, Xiangyu Zhang, Yao Cheng, Zhihao Qi, Ke Ye, Kuojun Zhang, Sheng Jiang, Yi Liu, Yibei Xiao, Tianyu Wang
Discovery of Novel PD-L1 Inhibitors That Induce the Dimerization, Internalization, and Degradation of PD-L1 Based on the Fragment Coupling Strategy. Journal of medicinal chemistry 66 (24) (2023)
Tianyu Wang, Kaizhen Wang, Yu Zhang, Kuojun Zhang, Shi Cai, Sheng Jiang, Yibei Xiao, Xiangyu Zhang
Novel Benzimidazoles as Potent Small-Molecule Inhibitors and Degraders of V-Domain Ig Suppressor of T-Cell Activation (VISTA). Journal of medicinal chemistry (2023)
Kaizhen Wang, Xiangyu Zhang, Yao Cheng, Zhihao Qi, Ke Ye, Kuojun Zhang, Sheng Jiang, Yi Liu, Yibei Xiao, Tianyu Wang
Discovery of Novel PD-L1 Inhibitors That Induce the Dimerization, Internalization, and Degradation of PD-L1 Based on the Fragment Coupling Strategy. Journal of medicinal chemistry 66 (24) (2023)
Kaizhen Wang, Xiangyu Zhang, Yao Cheng, Zhihao Qi, Ke Ye, Kuojun Zhang, Sheng Jiang, Yi Liu, Yibei Xiao, Tianyu Wang
Discovery of Novel PD-L1 Inhibitors That Induce the Dimerization, Internalization, and Degradation of PD-L1 Based on the Fragment Coupling Strategy. Journal of medicinal chemistry (2023)